A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor
Clinical trial NCT03312738 · COMPLETED
Trial details
- NCT number
- NCT03312738
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2022-04-25
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.